2023-506589-30-00
CTIS ↗
0.9% Sodium Chloride, JNJ-78901563
Invasive Extraintestinal Pathogenic Escherichia coli Disease
pharma · Invasive Extraintestinal Pathogenic Escherichia coli Disease · HIV-1 Infection
Zhejiang Xianju Pharmaceutical
Xian-Janssen Pharmaceutical
Zhejiang Xianju Pharmaceutical trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
西安, CN HQ
146 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 西安, CN
- Employees
- 146
- Programs
- 2
- Drugs
- 5
- Patents
- 0
Zhejiang Xianju Pharmaceutical clinical trials
Registry index of 2 ClinicalTrials.gov studies linked to Zhejiang Xianju Pharmaceutical programs — each row shows trial ID, program name, phase, status, and indication.
Zhejiang Xianju Pharmaceutical trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Zhejiang Xianju Pharmaceutical.